Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Direct Acting Antiviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02607800
What this trial is testing

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

Who this might be right for
Hepatitis C
Gilead Sciences 943
Testing effectiveness (Phase 2)Study completedNCT01225380
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C Infection
Gilead Sciences 324
Large-scale testing (Phase 3)Study completedNCT02399345
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults

Who this might be right for
Chronic Hepatitis C Virus (HCV Infection Genotype 1)
AbbVie 10
Not applicableUnknownNCT05506475
What this trial is testing

Evaluation of HCV Care and Treatment for HIV-HCV Co-infected Patients in Decentralised Areas in Vietnam

Who this might be right for
HIV InfectionHepatitis C Infection
Institut Pasteur 400
Post-approval studies (Phase 4)WithdrawnNCT02959359
What this trial is testing

DAA in the Risk of Recurrence After Curative Treatment of HCC

Who this might be right for
Hepatocellular Carcinoma
Taipei Veterans General Hospital, Taiwan
Not applicableStudy completedNCT06829966
What this trial is testing

Impact of Direct-acting Antiviral Drugs on The Patterns of Gut Microbiota in Patients With HCV Related Chronic Liver Diseases

Who this might be right for
Intestinal Microbiota Between Different Groups
Assiut University 30
Not applicableStudy completedNCT03423641
What this trial is testing

An Observational Study of the Safety of Direct-acting Antivirals in Patients With Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Kaiser Permanente 33,808
Testing effectiveness (Phase 2)Study completedNCT02105454
What this trial is testing

Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin in Participants With Chronic Hepatitis C Who Failed Prior Direct-Acting Antiviral Therapy (MK-5172-048)

Who this might be right for
Hepatitis C Virus
Merck Sharp & Dohme LLC 79
Testing effectiveness (Phase 2)Study completedNCT03724149
What this trial is testing

Transplanting Hepatitis C Lungs Into Negative Lung Recipients

Who this might be right for
Lung Diseases
University of Pennsylvania 10
Post-approval studies (Phase 4)Study completedNCT02874066
What this trial is testing

PrOD for Non-Cirrhotic Patients With HCV-1b Receiving Hemodialysis

Who this might be right for
Hepatitis Viruses
National Taiwan University Hospital 46
Not applicableStudy completedNCT07687758
What this trial is testing

Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP Score

Who this might be right for
Hepatitis C Virus InfectionCompensated Advanced Chronic Liver DiseaseHepatocellular Carcinoma (HCC)
Siriraj Hospital 571
Not applicableStudy completedNCT01457768
What this trial is testing

A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 570
Not applicableStudy completedNCT03602703
What this trial is testing

Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs

Who this might be right for
Drug-Induced Liver Injury
Assiut University 42
Not applicableStudy completedNCT03063723
What this trial is testing

Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs

Who this might be right for
Chronic Hepatitis C (Disorder)
Third Affiliated Hospital, Sun Yat-Sen University 25
Not applicableStudy completedNCT05452187
What this trial is testing

Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study

Who this might be right for
Inflammatory Bowel DiseasesHepatitis C Virus Infection
Hospital Mutua de Terrassa 79
Not applicableStudy completedNCT03248622
What this trial is testing

Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection

Who this might be right for
Hepatitis B
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 79
Testing effectiveness (Phase 2)Study completedNCT01808248
What this trial is testing

Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3

Who this might be right for
Hepatitis C
Gilead Sciences 47
Not applicableEnded earlyNCT03483987
What this trial is testing

Re-treatment of HCV Following DAA Failure

Who this might be right for
Chronic Hepatitis C
Sanjay Gandhi Postgraduate Institute of Medical Sciences 18
Post-approval studies (Phase 4)Ended earlyNCT05717400
What this trial is testing

Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy

Who this might be right for
Liver Cancer
M.D. Anderson Cancer Center 2
Post-approval studies (Phase 4)Study completedNCT03420300
What this trial is testing

EBR/GZR for HCV-1b Patients Receiving Hemodialysis

Who this might be right for
Hepatitis C
National Taiwan University Hospital 40
Next Page